Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome

被引：5
|
作者：
Dai, Cong [1 ]
Jiang, Min [1 ]
Sun, Ming-Jun [1 ]
机构：
[1] China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R China
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 06期
关键词：
BACTERIAL OVERGROWTH;
D O I：
10.1053/j.gastro.2016.09.068
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1629 / +
页数：2
相关论文
共 50 条
  • [1] Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome
    Kane, John S.
    Ford, Alexander C.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (04) : 431 - 442
  • [2] Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome Reply
    Lembo, Anthony J.
    GASTROENTEROLOGY, 2017, 152 (06) : 1630 - +
  • [3] Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
    Lembo, Anthony
    Pimentel, Mark
    Rao, Satish S.
    Schoenfeld, Philip
    Cash, Brooks
    Weinstock, Leonard B.
    Paterson, Craig
    Bortey, Enoch
    Forbes, William P.
    GASTROENTEROLOGY, 2016, 151 (06) : 1113 - 1121
  • [4] RIFAXIMIN IS A SAFE THERAPY FOR DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME
    Weinstock, Leonard B.
    Pimentel, Mark
    Heimanson, Zeev
    Lembo, Anthony
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S331 - S332
  • [5] Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndrome
    Bruzzese, Eugenia
    Pesce, Marcella
    Sarnelli, Giovanni
    Guarino, Alfredo
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (07) : 753 - 760
  • [6] Psychosocial determinants of rifaximin adherence for the treatment of diarrhea-predominant irritable bowel syndrome (IBS)
    Sherwin, L.
    Krisanabud, P.
    Deroche, C.
    Matteson-Kome, M.
    Ruppar, T.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30
  • [7] Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
    Lacy, Brian E.
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2016, 9 : 7 - 17
  • [8] Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
    Ozdener, Ayse Elif
    Rivkin, Anastasia
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2827 - 2840
  • [9] Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline
    Rivkin, Anastasia
    Rybalov, Sergey
    PHARMACOTHERAPY, 2016, 36 (03): : 300 - 316
  • [10] Evaluation of Crofelemer in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome Patients
    Mangel, Allen W.
    Chaturvedi, Pravin
    DIGESTION, 2008, 78 (04) : 180 - 186
12345